CanadaBis Capital (TSXV:CANB) ROE % Adjusted to Book Value: -9.35% (As of Oct. 2025)


What is CanadaBis Capital ROE % Adjusted to Book Value?

CanadaBis Capital TSXV:CANB ROE % Adjusted to Book Value is -9.35% as of Oct. 2025. The stock has 6 warning signs investors should review.

CanadaBis Capital's ROE % for the quarter that ended in Oct. 2025 was -6.64%. CanadaBis Capital's PB Ratio for the quarter that ended in Oct. 2025 was 0.71. CanadaBis Capital's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2025 was -9.35%.

CanadaBis Capital ROE % Adjusted to Book Value Related Terms

CanadaBis Capital ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for CanadaBis Capital's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanadaBis Capital ROE % Adjusted to Book Value Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.57 15.48 16.27 -1.11 -13.95

CanadaBis Capital Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.96 5.65 -1.30 -75.66 -9.35

TSXV:CANB vs NPHC, BSPK, CPMD: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CanadaBis Capital ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's ROE % Adjusted to Book Value falls into.


CanadaBis Capital ROE % Adjusted to Book Value Calculation

CanadaBis Capital's ROE % Adjusted to Book Value for the fiscal year that ended in Jul. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-11.02% / 0.79
=-13.95%

CanadaBis Capital's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.64% / 0.71
=-9.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -9.35% mean?
CanadaBis Capital (TSXV:CANB) has a ROE % Adjusted to Book Value of -9.35% as of Oct. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CanadaBis Capital and its competitors.
Is CanadaBis Capital's ROE % Adjusted to Book Value too high?
CanadaBis Capital's current ROE % Adjusted to Book Value is -9.35%.
How does CanadaBis Capital's ROE % Adjusted to Book Value compare to NPHC and BSPK?
CanadaBis Capital's ROE % Adjusted to Book Value of -9.35% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on CanadaBis Capital and its competitors. CanadaBis Capital's current ROE % Adjusted to Book Value is -9.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanadaBis Capital stock overvalued right now?
CanadaBis Capital (TSXV:CANB) has a current ROE % Adjusted to Book Value of -9.35%. The stock's GF Value™ is C$0.07, compared to a current price of C$0.02 — trading 78.6% below its estimated fair value. The current ROE % Adjusted to Book Value is -9.35%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For CanadaBis Capital (TSXV:CANB), the current ROE % Adjusted to Book Value is -9.35% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanadaBis Capital Business Description

Other Exchanges CNADF:USA
Address 255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.